German medical lab equipment maker Sartorius AG has reported lower earnings and revenue for the full fiscal year 2023 compared to 2022. The company on Friday cited soft demand that resulted in weak results across the entire life science sector for the weaker figures. However, the company said it expects profitable growth in fiscal 2024 and outlined its medium-term ambition through to 2028, expecting double-digit annual sales revenue growth. Yearly earnings fell 48.3% to €338.5 million ($366.2 million), or €4.94 per share, from €655.4 million, or €9.57 per share, of last year. Revenue dropped 1…